Karolinska University Study Shows Chemo-Free Regimen Feasible for Indolent Lymphoma

Nov 29, 2018 | Chemo Free Regiment, Chemotherapy, Oncology

University of Karolinska and other Nordic researchers reveal that more than a third of patients with symptomatic indolent lymphoma required no chemotherapy during more than 10 years of follow-up after initial treatment with Roche’s (rituximab (Rituxan).

Lead Research/Investigator

Sandra Lockmer, MD, of Karolinska University


Pin It on Pinterest